Schmdit, T. ; Wiesbeck, M. ; Egert, L. ; Truong, T.-T. ; Danese, A.* ; Voshagen, L.* ; Imhof, S.* ; Iraci Borgia, M.* ; Deeksha ; Neuner, A.M. ; Köferle, A. ; Geerlof, A. ; Mourao, A. ; Stricker, S.H.
Efficient DNA- and virus-free engineering of cellular transcriptomic states using dCas9 ribonucleoprotein (dRNP) complexes.
Nucleic Acids Res. 53:gkaf235 (2025)
For genome editing, the use of CRISPR ribonucleoprotein (RNP) complexes is well established and often the superior choice over plasmid-based or viral strategies. RNPs containing dCas9 fusion proteins, which enable the targeted manipulation of transcriptomes and epigenomes, remain significantly less accessible. Here, we describe the production, delivery, and optimization of second generation CRISPRa RNPs (dRNPs). We characterize the transcriptional and cellular consequences of dRNP treatments in a variety of human target cells and show that the uptake is very efficient. The targeted activation of genes demonstrates remarkable potency, even for genes that are strongly silenced, such as developmental master transcription factors. In contrast to DNA-based CRISPRa strategies, gene activation is immediate and characterized by a sharp temporal precision. We also show that dRNPs allow very high-target multiplexing, enabling undiminished gene activation of multiple genes simultaneously. Applying these insights, we find that intensive target multiplexing at single promoters synergistically elevates gene transcription. Finally, we demonstrate in human stem and differentiated cells that the preferable features of dRNPs allow to instruct and convert cell fates efficiently without the need for DNA delivery or viral vectors.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Gene-expression; In-vivo; Rna; Crispr; Activation; Delivery; System; Cas9; Platform; Protein
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2025
Prepublished im Jahr
0
HGF-Berichtsjahr
2025
ISSN (print) / ISBN
0305-1048
e-ISSN
1362-4962
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 53,
Heft: 6,
Seiten: ,
Artikelnummer: gkaf235
Supplement: ,
Reihe
Verlag
Oxford University Press
Verlagsort
Great Clarendon St, Oxford Ox2 6dp, England
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30204 - Cell Programming and Repair
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Stem Cell and Neuroscience
Enabling and Novel Technologies
PSP-Element(e)
G-500800-001
G-500892-001
G-503000-001
Förderungen
Humanities Research Council of Canada
natural sciences and engineering research council of canada
CIHR
REGENERAR
Helmholtz Zentrum Munchen
International Helmholtz-Edinburgh Research School for Epigenetics
EpiCrossBorders
Copyright
Erfassungsdatum
2025-05-05